Diagnostics

SOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of Pathology

BOSTON and ROLLE, Switzerland, Sept. 5, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader...

Dr. Vuong Trieu, Developer of Novel Oncology and Immunotherapy Assets, Leads Oncotelic Therapeutics’ Commitment to Innovation, Life-Saving Therapies

Dr. Trieu’s prolific career includes multibillion-dollar drug discoveries targeting cancers of the breast, pancreas and non-small cell lung cancer, among...

Biotia and Hospital for Special Surgery Announce Collaboration to Advance Diagnostics for Prosthetic Joint Infections

NEW YORK--(BUSINESS WIRE)--Biotia, a health technology company leveraging next-generation sequencing (NGS) and artificial intelligence (AI), and Hospital for Special Surgery...

Biotia and Hospital for Special Surgery Announce Collaboration to Advance Diagnostics for Prosthetic Joint Infections

NEW YORK--(BUSINESS WIRE)--Biotia, a health technology company leveraging next-generation sequencing (NGS) and artificial intelligence (AI), and Hospital for Special Surgery...

Mass Spectrometry Market Size to Reach USD 10.13 Billion by 2030, Fueled by AI, Multi-Omics, and Next-Gen Healthcare | Mordor Intelligence

HYDERABAD, India, Sept. 2, 2025 /PRNewswire/ -- According to Mordor Intelligence, the global mass spectrometry market, valued at USD 7.16 billion...

error: Content is protected !!